0,935  0,005  Apoptosis agonist
0,917  0,005  Antiinflammatory
0,884  0,004  Antineoplastic (melanoma)
0,881  0,008  Transcription factor NF kappa B inhibitor
0,865  0,005  Antineoplastic (breast cancer)
0,858  0,005  Antineoplastic (lung cancer)
0,823  0,004  Chemopreventive
0,811  0,004  Nitric oxide antagonist
0,808  0,002  Antineoplastic (endocrine cancer)
0,806  0,007  Antineoplastic (colorectal cancer)
0,802  0,007  Antineoplastic (colon cancer)
0,789  0,004  AR expression inhibitor
0,787  0,005  Antineoplastic (ovarian cancer)
0,775  0,004  Antineoplastic (pancreatic cancer)
0,778  0,007  Antileukemic
0,725  0,008  Prostate cancer treatment
0,717  0,005  Hepatic disorders treatment
0,712  0,006  NOS2 expression inhibitor
0,698  0,007  Antineoplastic (cervical cancer)
0,687  0,025  Caspase 9 stimulant
0,635  0,005  UGT1A4 substrate
0,625  0,005  Antiviral (HIV)
0,623  0,012  Bone diseases treatment
0,618  0,008  Apoptosis antagonist
0,611  0,010  Antiosteoporotic
0,602  0,005  Hair growth stimulant
0,599  0,005  Hepatoprotectant
0,581  0,004  Antiviral (Influenza A)
0,574  0,003  Interferon gamma antagonist
0,561  0,011  Antiprotozoal (Leishmania)
0,559  0,013  Caspase 3 stimulant
0,544  0,004  Antiviral (Influenza)
0,561  0,035  Antidiabetic
0,561  0,035  Cyclophilin D inhibitor
0,524  0,004  Abortion inducer
0,538  0,019  Chemoprotective
0,515  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,511  0,003  UGT2B9 substrate
0,539  0,037  TNF expression inhibitor
0,526  0,025  Antipruritic, allergic
0,505  0,011  ICAM1 expression inhibitor
0,510  0,017  Antineoplastic (glioma)
0,499  0,018  Antineoplastic (multiple myeloma)
0,480  0,005  Protein-tyrosine phosphatase inhibitor
0,493  0,021  Antioxidant
0,480  0,009  Antineoplastic (carcinoma)
0,474  0,011  Antineoplastic (lymphocytic leukemia)
0,464  0,007  Antiacne
0,481  0,024  Sensitization
0,464  0,008  Contraceptive
0,469  0,014  Antihypertriglyceridemic
0,467  0,014  Angiogenesis stimulant
0,475  0,028  Cytotoxic
0,454  0,008  Prostate disorders treatment
0,483  0,038  Immunosuppressant
0,452  0,007  UGT2B7 substrate
0,444  0,005  Insulin sensitizer
0,453  0,020  Hypoxia-inducible factor 1 alpha inhibitor
0,464  0,034  Immunostimulant
0,445  0,016  UDP-glucuronosyltransferase substrate
0,445  0,016  Antihypoxic
0,441  0,013  UGT1A1 substrate
0,435  0,008  Phospholipase C inhibitor
0,428  0,010  Sodium/bile acid cotransporter inhibitor
0,444  0,029  NOS3 expression inhibitor
0,417  0,006  Insulin secretagoues
0,435  0,023  UGT2B4 substrate
0,422  0,012  Antiviral (Herpes)
0,402  0,007  Antiviral (Hepatitis B)
0,403  0,008  Lipocortins synthesis antagonist
0,419  0,025  Antineoplastic (glioblastoma multiforme)
0,386  0,003  Transcription factor NF kappa B stimulant
0,391  0,012  Platelet adhesion inhibitor
0,385  0,013  Prostatic (benign) hyperplasia treatment
0,410  0,047  Cholesterol antagonist
0,404  0,044  Respiratory analeptic
0,383  0,025  Vascular (periferal) disease treatment
0,383  0,032  Proliferative diseases treatment
0,419  0,068  Antibacterial
0,356  0,007  Antifungal enhancer
0,382  0,033  Cardiovascular analeptic
0,359  0,016  Diuretic
0,351  0,009  Acute respiratory distress syndrome (ARDS) treatment
0,343  0,003  5-Alpha-reductase inhibitor
0,369  0,033  Hypoglycemic
0,332  0,004  Inducible nitric-oxide synthase inhibitor
0,359  0,031  Antineoplastic (liver cancer)
0,341  0,016  Antiviral (Hepatitis)
0,359  0,036  Tumour necrosis factor alpha release inhibitor
0,388  0,067  CYP2C9 substrate
0,362  0,041  Antidiabetic (type 2)
0,334  0,013  Liver fibrosis treatment
0,338  0,017  Melanin inhibitor
0,321  0,003  Aldosterone antagonist
0,330  0,018  Antipruritic, non-allergic
0,320  0,008  3C-like protease (Human coronavirus) inhibitor
0,347  0,037  Antineoplastic (renal cancer)
0,359  0,051  Antihypercholesterolemic
0,346  0,038  Carcinogenic
0,364  0,056  Antifungal
0,357  0,050  Teratogen
0,321  0,016  Monophenol monooxygenase inhibitor
0,313  0,010  Cholesterol synthesis inhibitor
0,351  0,050  Metabolic disease treatment
0,337  0,037  Transcription factor STAT3 inhibitor
0,357  0,071  Vasodilator, peripheral
0,311  0,026  Gastrin inhibitor
0,298  0,020  Skin whitener
0,332  0,058  Analeptic
0,304  0,031  Antihelmintic
0,323  0,054  Embryotoxic
0,317  0,050  Renal disease treatment
0,307  0,041  Antiparasitic
0,263  0,008  Contraceptive female
0,260  0,011  UGT2B10 substrate
0,313  0,064  Lipoprotein disorders treatment
0,283  0,037  Antihypotensive
0,247  0,005  Vanilloid agonist
0,312  0,072  Antineoplastic (brain cancer)
0,246  0,011  Alcohol dehydrogenase substrate
0,240  0,008  Arachidonic acid antagonist
0,235  0,004  Antiviral (SARS coronavirus)
0,235  0,004  Antiviral (Coronavirus)
0,252  0,022  Antiviral (Hepatitis C)
0,289  0,060  Antipyretic
0,281  0,056  5 Hydroxytryptamine uptake stimulant
0,254  0,029  Antineoplastic (squamous cell carcinoma)
0,232  0,011  Choleretic
0,293  0,079  Interleukin 2 agonist
0,221  0,008  TRPA1 agonist
0,236  0,030  Protein kinase stimulant
0,270  0,063  Myocardial infarction treatment
0,265  0,062  Vasodilator
0,207  0,005  Phosphorylase inhibitor
0,233  0,032  UGT2B15 substrate
0,191  0,002  Heme oxygenase stimulant
0,208  0,019  Farnesoid X receptor antagonist
0,269  0,081  CYP2C19 substrate
0,186  0,003  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,274  0,092  Antineoplastic (osteosarcoma)
0,183  0,004  Glycine receptor antagonist
0,205  0,027  DNA polymerase I inhibitor
0,198  0,021  Endometrios treatment
0,258  0,081  Transcription factor STAT inhibitor
0,182  0,007  Anabolic
0,245  0,070  DNA synthesis inhibitor
0,237  0,065  Antiulcerative
0,221  0,052  P-glycoprotein inhibitor
0,172  0,003  Na+ K+ transporting ATPase inhibitor
0,215  0,047  Diabetic nephropathy treatment
0,178  0,013  Actinic keratosis treatment
0,224  0,061  Wound healing agent
0,170  0,009  UGT2B11 substrate
0,239  0,081  Antidiabetic symptomatic
0,183  0,026  Cyclooxygenase 3 inhibitor
0,178  0,026  Expectorant
0,219  0,069  Antialcoholic
0,167  0,019  AMP-activated protein kinase stimulant
0,197  0,054  Antineoplastic (gastric cancer)
0,191  0,056  UGT1A3 substrate
0,229  0,101  5 Hydroxytryptamine release stimulant
0,126  0,005  Diacylglycerol O-acyltransferase inhibitor
0,224  0,106  Amyotrophic lateral sclerosis treatment
0,148  0,030  UGT2B1 substrate
0,197  0,080  Neurotrophic factor enhancer
0,149  0,038  Microtubule formation inhibitor
0,120  0,011  Anticholelithogenic
0,127  0,028  Topoisomerase II alpha inhibitor
0,196  0,097  UGT1A6 substrate
0,109  0,010  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,120  0,022  Contraceptive male
0,134  0,035  Antiinfertility, female
0,104  0,006  RNA-directed RNA polymerase stimulant
0,113  0,015  Postmenopausal disorders treatment
0,143  0,047  Growth stimulant
0,131  0,036  Antineoplastic antibiotic
0,151  0,058  Bone formation stimulant
0,112  0,022  CDC25A inhibitor
0,112  0,023  3C-Like protease (SARS coronavirus) inhibitor
0,149  0,065  Adenylate cyclase stimulant
0,127  0,043  Estrogen antagonist
0,088  0,005  Farnesoid X receptor agonist
0,132  0,049  Topoisomerase I inhibitor
0,118  0,039  Nitric-oxide synthase inhibitor
0,110  0,031  Bile acid receptor antagonist
0,165  0,087  Succinate dehydrogenase inhibitor
0,121  0,044  Antiprotozoal (Toxoplasma)
0,086  0,010  Lipocortins synthesis agonist
0,077  0,006  5-Alpha-reductase 2 inhibitor
0,097  0,026  Ca(v)3.1 blocker
0,136  0,067  Renal failure treatment
0,117  0,049  Beta glucuronidase inhibitor
0,121  0,054  Aldehyde dehydrogenase substrate
0,090  0,024  Aromatase inhibitor
0,086  0,021  Androgen agonist
0,130  0,066  Vanilloid 1 agonist
0,179  0,116  Free radical scavenger
0,125  0,063  Topoisomerase II inhibitor
0,142  0,081  Antidiarrheal
0,120  0,061  Shock treatment
0,064  0,006  5-Alpha-reductase 1 inhibitor
0,077  0,019  Botulinum neurotoxin type A inhibitor
0,101  0,044  Ornithine decarboxylase inhibitor
0,102  0,047  ABCA1 expression enhancer
0,090  0,037  Keratolytic
0,097  0,044  Antispirochetal
0,103  0,050  Posttraumatic stress disorder treatment
0,060  0,007  Glucose-6-phosphate dehydrogenase inhibitor
0,221  0,170  Stroke treatment
0,063  0,013  Retinoid X receptor agonist
0,099  0,050  Paget's disease treatment
0,105  0,056  Estrogen receptor beta antagonist
0,055  0,007  Estrone sulfatase inhibitor
0,070  0,022  Postcoital contraceptive
0,155  0,108  Anesthetic general
0,107  0,060  Protease inhibitor
0,124  0,078  Antihemorrhagic
0,084  0,042  Estrogen receptor alpha antagonist
0,064  0,023  Pregnane X receptor antagonist
0,064  0,024  Acetyl-CoA transferase 2 inhibitor
0,066  0,028  Estrogen agonist
0,081  0,042  Lipase inhibitor
0,056  0,019  Microtubule stabilization
0,146  0,109  Sedative
0,149  0,115  Toxic, respiratory center
0,109  0,075  Antiviral (CMV)
0,044  0,011  Tubulin agonist
0,123  0,091  Antimutagenic
0,123  0,093  Antieczematic
0,087  0,057  Antineoplastic alkaloid
0,130  0,101  Phospholipase A2 inhibitor
0,066  0,038  Nitric oxide donor
0,098  0,070  Gout treatment
0,046  0,018  Retinoic acid alpha receptor agonist
0,147  0,119  Psychostimulant
0,033  0,007  Vanilloid 2 agonist
0,041  0,015  Melatonin 2 agonist
0,086  0,059  Androgen antagonist
0,035  0,008  Retinoid X gamma receptor agonist
0,179  0,154  Cardioprotectant
0,040  0,015  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,054  0,030  Anesthetic inhalation
0,033  0,009  Retinoid X gamma receptor antagonist
0,051  0,028  Cholesterol esterase inhibitor
0,144  0,121  LDLR expression enhancer
0,215  0,192  Antiobesity
0,123  0,101  CC chemokine 6 receptor antagonist
0,028  0,009  Retinoid X beta receptor agonist
0,061  0,042  TRPA1 antagonist
0,027  0,009  Retinoic acid gamma receptor agonist
0,156  0,138  Antineoplastic (lymphoma)
0,115  0,099  Lipid peroxidase inhibitor
0,026  0,009  Corticosteroid-like
0,042  0,026  Kainate receptor agonist
0,024  0,009  Progesterone agonist
0,027  0,012  Retinoic acid receptor agonist
0,121  0,106  Antianemic
0,129  0,114  Antihelmintic (Nematodes)
0,060  0,046  Antimycoplasmal
0,040  0,027  GABA uptake inhibitor
0,020  0,008  Telomerase stimulant
0,052  0,040  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,034  0,022  Glucocorticoid antagonist
0,016  0,004  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,090  0,079  Skin irritative effect
0,044  0,034  Parathyroid hormone antagonist
0,021  0,012  Retinoic acid beta receptor agonist
0,046  0,040  Antiviral (Herpesvirus 3, Human)
0,176  0,171  UGT1A9 substrate
0,082  0,078  SULT1E1 substrate
0,084  0,079  Antiviral (Rhinovirus)
0,066  0,062  Glycine receptor agonist
0,021  0,017  Vitamin D receptor antagonist
0,020  0,017  Retinoid X beta receptor antagonist
0,070  0,067  Narcotic antagonist
0,211  0,208  Atherosclerosis treatment
0,029  0,027  Estrogen receptor alpha agonist
0,019  0,017  Retinoic acid alpha receptor antagonist
0,148  0,147  Pneumotoxic

